{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:27:13Z","timestamp":1792520833304,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019889","name":"Weston Family Foundation","doi-asserted-by":"publisher","award":["GR015436"],"award-info":[{"award-number":["GR015436"]}],"id":[{"id":"10.13039\/100019889","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anxiety is a prevalent non-motor symptom of Parkinson\u2019s disease (PD), yet treatment options remain limited. This randomized, double-blind, placebo-controlled trial evaluated the effects of a 12-week probiotic supplement containing nine bacterial strains (\n                    <jats:italic>Bifidobacterium bifidum<\/jats:italic>\n                    W23,\n                    <jats:italic>Bifidobacterium lactis<\/jats:italic>\n                    W51 and W52,\n                    <jats:italic>Lactobacillus acidophilus<\/jats:italic>\n                    W37,\n                    <jats:italic>Levilactobacillus brevis<\/jats:italic>\n                    W63,\n                    <jats:italic>Lacticaseibacillus casei<\/jats:italic>\n                    W56,\n                    <jats:italic>Ligilactobacillus salivarius<\/jats:italic>\n                    W24, and\n                    <jats:italic>Lactococcus lactis<\/jats:italic>\n                    W19 and W58) on anxiety symptoms in 61 individuals with PD and clinically significant anxiety. Both the probiotic (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930) and placebo (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200931) groups showed significant within-group improvements on the Parkinson Anxiety Scale, with no significant between-group differences. The probiotic group showed a statistically significant improvement on the Montreal Cognitive Assessment compared with placebo (adjusted mean difference of 1.1 points; 95% confidence interval: 0.04\u20132.1;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.043). No treatment effects were seen on other secondary outcomes, including depression, constipation, or motor symptoms. No significant between-group differences in gut microbiota composition or systemic inflammatory markers were observed. While the multi-strain probiotic did not reduce anxiety more than placebo, its potential cognitive effects warrant further investigation in larger trials. This trial was registered on ClinicalTrials.gov (NCT03968133) on May 28, 2019.\n                  <\/jats:p>","DOI":"10.1038\/s41531-026-01364-1","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:25:05Z","timestamp":1777123505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Probiotic supplementation for anxiety symptoms in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1038","volume":"12","author":[{"given":"Joyce S. T.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kira N.","family":"Tosefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Uzelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai S.","family":"Cirstea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio","family":"Pio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"Vila-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Brett","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Appel-Cresswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.26643","volume":"31","author":"MPG Broen","year":"2016","unstructured":"Broen, M. P. G., Narayen, N. E., Kuijf, M. L., Dissanayaka, N. N. W. & Leentjens, A. F. G. Prevalence of anxiety in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 31, 1125\u20131133 (2016).","journal-title":"Mov. Disord."},{"key":"1364_CR2","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1212\/WNL.0000000000004771","volume":"90","author":"B Mele","year":"2018","unstructured":"Mele, B. et al. Detecting anxiety in individuals with Parkinson disease: a systematic review. Neurology 90, e39\u2013e47 (2018).","journal-title":"Neurology"},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1017\/S1041610215002410","volume":"28","author":"NNW Dissanayaka","year":"2016","unstructured":"Dissanayaka, N. N. W. et al. Disease-specific anxiety symptomatology in Parkinson\u2019s disease. Int. Psychogeriatr. 28, 1153\u20131163 (2016).","journal-title":"Int. Psychogeriatr."},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1037\/neu0000353","volume":"31","author":"GO Reynolds","year":"2017","unstructured":"Reynolds, G. O., Hanna, K. K., Neargarder, S. & Cronin-Golomb, A. The relation of anxiety and cognition in Parkinson\u2019s disease. Neuropsychology 31, 596\u2013604 (2017).","journal-title":"Neuropsychology"},{"key":"1364_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41531-023-00512-1","volume":"9","author":"EK Blundell","year":"2023","unstructured":"Blundell, E. K., Grover, L. E., Stott, J. & Schrag, A. The experience of anxiety for people with Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 75 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1364_CR6","first-page":"640707","volume":"2012","author":"KK Hanna","year":"2012","unstructured":"Hanna, K. K. & Cronin-Golomb, A. Impact of anxiety on quality of life in Parkinson\u2019s disease. Parkinsons Dis. 2012, 640707 (2012).","journal-title":"Parkinsons Dis."},{"key":"1364_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.parkreldis.2019.05.009","volume":"65","author":"GD Kuhlman","year":"2019","unstructured":"Kuhlman, G. D., Flanigan, J. L., Sperling, S. A. & Barrett, M. J. Predictors of health-related quality of life in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 65, 86\u201390 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1002\/mds.23394","volume":"25","author":"DA Gallagher","year":"2010","unstructured":"Gallagher, D. A., Lees, A. J. & Schrag, A. What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them?. Mov. Disord. 25, 2493\u20132500 (2010).","journal-title":"Mov. Disord."},{"key":"1364_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jagp.2012.10.023","volume":"21","author":"GM Pontone","year":"2013","unstructured":"Pontone, G. M. et al. Pharmacologic treatment of anxiety disorders in Parkinson disease. Am. J. Geriatr. Psychiatry 21, 520\u2013528 (2013).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.parkreldis.2014.11.019","volume":"21","author":"S Rutten","year":"2015","unstructured":"Rutten, S. et al. Anxiety in Parkinson\u2019s disease: symptom dimensions and overlap with depression and autonomic failure. Parkinsonism Relat. Disord. 21, 189\u2013193 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1364_CR11","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/mds.27465","volume":"33","author":"RMJ van der Velden","year":"2018","unstructured":"van der Velden, R. M. J., Broen, M. P. G., Kuijf, M. L. & Leentjens, A. F. G. Frequency of mood and anxiety fluctuations in Parkinson\u2019s disease patients with motor fluctuations: a systematic review. Mov. Disord. 33, 1521\u20131527 (2018).","journal-title":"Mov. Disord."},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-019-0102-8","volume":"5","author":"GM Pontone","year":"2019","unstructured":"Pontone, G. M. et al. Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson\u2019s disease. NPJ Parkinsons Dis 5, 30 (2019).","journal-title":"NPJ Parkinsons Dis"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/practneurol-2017-001650","volume":"17","author":"MHM Timmer","year":"2017","unstructured":"Timmer, M. H. M., van Beek, M. H. C. T., Bloem, B. R. & Esselink, R. A. J. What a neurologist should know about depression in Parkinson\u2019s disease. Pract. Neurol. 17, 359\u2013368 (2017).","journal-title":"Pract. Neurol."},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi, K. et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014an evidence-based medicine review. Mov. Disord. 34, 180\u2013198 (2019).","journal-title":"Mov. Disord."},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","volume":"21","author":"D Weintraub","year":"2022","unstructured":"Weintraub, D. et al. The neuropsychiatry of Parkinson\u2019s disease: advances and challenges. Lancet Neurol 21, 89\u2013102 (2022).","journal-title":"Lancet Neurol"},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.parkreldis.2020.10.020","volume":"81","author":"RB Schneider","year":"2020","unstructured":"Schneider, R. B. et al. A trial of buspirone for anxiety in Parkinson\u2019s disease: safety and tolerability. Parkinsonism Relat. Disord. 81, 69\u201374 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/mds.28533","volume":"36","author":"AJH Moonen","year":"2021","unstructured":"Moonen, A. J. H. et al. Cognitive behavioral therapy for anxiety in Parkinson\u02bcs disease: a randomized controlled trial. Mov. Disord. 36, 2539\u20132548 (2021).","journal-title":"Mov. Disord."},{"key":"1364_CR18","doi-asserted-by":"publisher","first-page":"e2232133","DOI":"10.1001\/jamanetworkopen.2022.32133","volume":"5","author":"JQ Fan","year":"2022","unstructured":"Fan, J. Q. et al. Effectiveness of acupuncture for anxiety among patients with Parkinson disease: a randomized clinical trial. JAMA Netw. Open 5, e2232133 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1364_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2013","unstructured":"Foster, J. A. & McVey Neufeld, K. A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36, 305\u2013312 (2013).","journal-title":"Trends Neurosci"},{"key":"1364_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","volume":"1693","author":"P Strandwitz","year":"2018","unstructured":"Strandwitz, P. Neurotransmitter modulation by the gut microbiota. Brain Res. 1693, 128\u2013133 (2018).","journal-title":"Brain Res."},{"key":"1364_CR21","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","volume":"87","author":"M Barichella","year":"2016","unstructured":"Barichella, M. et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease. Neurology 87, 1274\u20131280 (2016).","journal-title":"Neurology"},{"key":"1364_CR22","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.2147\/CIA.S106284","volume":"11","author":"D Georgescu","year":"2016","unstructured":"Georgescu, D., Ancusa, O. E., Georgescu, L. A., Ionita, I. & Reisz, D. Nonmotor gastrointestinal disorders in older patients with Parkinson\u2019s disease: is there hope?. Clin. Interv. Aging 11, 1601\u20131608 (2016).","journal-title":"Clin. Interv. Aging"},{"key":"1364_CR23","first-page":"289","volume":"21","author":"S Borzabadi","year":"2018","unstructured":"Borzabadi, S. et al. The effects of probiotic supplementation on gene expression related to inflammation, insulin and lipid in patients with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial. Arch. Iran. Med. 21, 289\u2013295 (2018).","journal-title":"Arch. Iran. Med."},{"key":"1364_CR24","doi-asserted-by":"publisher","first-page":"e0244680","DOI":"10.1371\/journal.pone.0244680","volume":"15","author":"A Ibrahim","year":"2020","unstructured":"Ibrahim, A. et al. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson\u2019s disease: a randomised controlled trial. PLoS ONE 15, e0244680 (2020).","journal-title":"PLoS ONE"},{"key":"1364_CR25","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1212\/WNL.0000000000010998","volume":"96","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Probiotics for constipation in Parkinson disease: a randomized placebo-controlled study. Neurology 96, e772\u2013e782 (2021).","journal-title":"Neurology"},{"key":"1364_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.parkreldis.2022.08.022","volume":"103","author":"Y Du","year":"2022","unstructured":"Du, Y. et al. Probiotics for constipation and gut microbiota in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 103, 92\u201397 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1364_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41531-022-00327-6","volume":"8","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease. NPJ Parkinsons Dis 8, 62 (2022).","journal-title":"NPJ Parkinsons Dis"},{"key":"1364_CR28","doi-asserted-by":"publisher","first-page":"6828","DOI":"10.1039\/D3FO00728F","volume":"14","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Effect of Lacticaseibacillus paracasei strain Shirota supplementation on clinical responses and gut microbiome in Parkinson\u2019s disease. Food Funct. 14, 6828\u20136839 (2023).","journal-title":"Food Funct."},{"key":"1364_CR29","doi-asserted-by":"publisher","first-page":"e137840","DOI":"10.5812\/ijpr-137840","volume":"22","author":"N Ghalandari","year":"2023","unstructured":"Ghalandari, N., Assarzadegan, F., Habibi, S. A. H., Esmaily, H. & Malekpour, H. Efficacy of probiotics in improving motor function and alleviating constipation in Parkinson\u2019s disease: a randomized controlled trial. Iran. J. Pharm. Res. 22, e137840 (2023).","journal-title":"Iran. J. Pharm. Res."},{"key":"1364_CR30","doi-asserted-by":"publisher","first-page":"105397","DOI":"10.1016\/j.jff.2022.105397","volume":"100","author":"S Mehrabani","year":"2023","unstructured":"Mehrabani, S., Khorvash, F., Heidari, Z., Tajabadi-Ebrahimi, M. & Amani, R. The effects of synbiotic supplementation on oxidative stress markers, mental status, and quality of life in patients with Parkinson\u2019s disease: a double-blind, placebo-controlled, randomized controlled trial. J. Funct. Foods 100, 105397 (2023).","journal-title":"J. Funct. Foods"},{"key":"1364_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/brainsci14111147","volume":"14","author":"L Magistrelli","year":"2024","unstructured":"Magistrelli, L. et al. The impact of probiotics on clinical symptoms and peripheral cytokines levels in Parkinson\u2019s disease: preliminary in vivo data. Brain Sci 14, 1147 (2024).","journal-title":"Brain Sci"},{"key":"1364_CR32","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1002\/mds.70047","volume":"40","author":"V Leta","year":"2025","unstructured":"Leta, V. et al. Effects of a four-strain probiotic on gut microbiota, inflammation, and symptoms in Parkinson\u2019s disease: a randomized clinical trial. Mov. Disord. 40, 2710\u20132721 (2025).","journal-title":"Mov. Disord."},{"key":"1364_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neubiorev.2019.03.023","volume":"102","author":"RT Liu","year":"2019","unstructured":"Liu, R. T., Walsh, R. F. L. & Sheehan, A. E. Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials. Neurosci. Biobehav. Rev. 102, 13\u201323 (2019).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1364_CR34","doi-asserted-by":"publisher","first-page":"e1504","DOI":"10.1093\/nutrit\/nuae177","volume":"83","author":"A Asad","year":"2025","unstructured":"Asad, A., Kirk, M., Zhu, S., Dong, X. & Gao, M. Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 83, e1504\u2013e1520 (2025).","journal-title":"Nutr. Rev."},{"key":"1364_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-023-00536-1","volume":"15","author":"JM Park","year":"2023","unstructured":"Park, J. M., Lee, S. C., Ham, C. & Kim, Y. W. Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson\u2019s disease: a meta-analysis of randomized controlled trials. Gut Pathog. 15, 9 (2023).","journal-title":"Gut Pathog."},{"key":"1364_CR36","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1139\/apnm-2018-0645","volume":"44","author":"AE Smith-Ryan","year":"2019","unstructured":"Smith-Ryan, A. E., Mock, M. G., Trexler, E. T., Hirsch, K. R. & Blue, M. N. M. Influence of a multistrain probiotic on body composition and mood in female occupational shift workers. Appl. Physiol. Nutr. Metab. 44, 765\u2013773 (2019).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"1364_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbi.2015.04.003","volume":"48","author":"L Steenbergen","year":"2015","unstructured":"Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J. A. & Colzato, L. S. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav. Immun. 48, 258\u2013264 (2015).","journal-title":"Brain Behav. Immun."},{"key":"1364_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2018.100141","volume":"10","author":"S Papalini","year":"2019","unstructured":"Papalini, S. et al. Stress matters: randomized controlled trial on the effect of probiotics on neurocognition. Neurobiol. Stress 10, 100141 (2019).","journal-title":"Neurobiol. Stress"},{"key":"1364_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/mds.21894","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Placebo response in Parkinson\u2019s disease: comparisons among 11 trials covering medical and surgical interventions. Mov. Disord. 23, 690\u2013699 (2008).","journal-title":"Mov. Disord."},{"key":"1364_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fpsyt.2019.00407","volume":"10","author":"I Kirsch","year":"2019","unstructured":"Kirsch, I. Placebo effect in the treatment of depression and anxiety. Front. Psychiatry 10, 407 (2019).","journal-title":"Front. Psychiatry"},{"key":"1364_CR41","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S1474-4422(16)00066-1","volume":"15","author":"F Benedetti","year":"2016","unstructured":"Benedetti, F., Carlino, E. & Piedimonte, A. Increasing uncertainty in CNS clinical trials: the role of placebo, nocebo, and Hawthorne effects. Lancet Neurol. 15, 736\u2013747 (2016).","journal-title":"Lancet Neurol."},{"key":"1364_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-024-02152-2","volume":"24","author":"T Saueressig","year":"2024","unstructured":"Saueressig, T., Pedder, H., Owen, P. J. & Belavy, D. L. Contextual effects: how to, and how not to, quantify them. BMC Med. Res. Methodol. 24, 35 (2024).","journal-title":"BMC Med. Res. Methodol."},{"key":"1364_CR43","first-page":"100222","volume":"6","author":"E Lindvall","year":"2024","unstructured":"Lindvall, E., Abzhandadze, T., Quinn, T. J., Sunnerhagen, K. S. & Lundstr\u00f6m, E. Is the difference real, is the difference relevant: the minimal detectable and clinically important changes in the Montreal Cognitive Assessment. Cereb. Circ. Cogn. Behav. 6, 100222 (2024).","journal-title":"Cereb. Circ. Cogn. Behav."},{"key":"1364_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40035-022-00323-z","volume":"11","author":"X Liang","year":"2022","unstructured":"Liang, X. et al. Gut microbiome, cognitive function and brain structure: a multi-omics integration analysis. Transl. Neurodegener. 11, 49 (2022).","journal-title":"Transl. Neurodegener."},{"key":"1364_CR45","doi-asserted-by":"publisher","first-page":"e2143941","DOI":"10.1001\/jamanetworkopen.2021.43941","volume":"5","author":"K Meyer","year":"2022","unstructured":"Meyer, K. et al. Association of the gut microbiota with cognitive function in midlife. JAMA Netw. Open 5, e2143941 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1364_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13195-025-01697-8","volume":"17","author":"SJ Son","year":"2025","unstructured":"Son, S. J. et al. Brain age mediates gut microbiome dysbiosis-related cognition in older adults. Alzheimers Res. Ther. 17, 52 (2025).","journal-title":"Alzheimers Res. Ther."},{"key":"1364_CR47","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/nutrit\/nuac113","volume":"81","author":"N Liu","year":"2023","unstructured":"Liu, N., Yang, D., Sun, J. & Li, Y. Probiotic supplements are effective in people with cognitive impairment: a meta-analysis of randomized controlled trials. Nutr. Rev. 81, 1091\u20131104 (2023).","journal-title":"Nutr. Rev."},{"key":"1364_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.gerinurse.2023.09.009","volume":"54","author":"J Kou","year":"2023","unstructured":"Kou, J. et al. Evaluation of improvement of cognitive impairment in older adults with probiotic supplementation: a systematic review and meta-analysis. Geriatr. Nurs. 54, 155\u2013162 (2023).","journal-title":"Geriatr. Nurs."},{"key":"1364_CR49","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1177\/25424823241289039","volume":"8","author":"S Tripathi","year":"2024","unstructured":"Tripathi, S. et al. The effect of probiotics on select cognitive domains in mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis. J. Alzheimers Dis. Rep. 8, 1422\u20131433 (2024).","journal-title":"J. Alzheimers Dis. Rep."},{"key":"1364_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jad.2019.04.097","volume":"253","author":"B Chahwan","year":"2019","unstructured":"Chahwan, B. et al. Gut feelings: a randomised, triple-blind, placebo-controlled trial of probiotics for depressive symptoms. J. Affect. Disord. 253, 317\u2013326 (2019).","journal-title":"J. Affect. Disord."},{"key":"1364_CR51","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/schbul\/sbae188","volume":"51","author":"J Borkent","year":"2025","unstructured":"Borkent, J., Ioannou, M., Neijzen, D., Haarman, B. C. M. & Sommer, I. E. C. Probiotic formulation for patients with bipolar or schizophrenia spectrum disorder: a double-blind, randomized placebo-controlled trial. Schizophr. Bull. 51, 1568\u20131580 (2025).","journal-title":"Schizophr. Bull."},{"key":"1364_CR52","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.ajcnut.2025.04.002","volume":"121","author":"J Eastwood","year":"2025","unstructured":"Eastwood, J. et al. Exploring the acute and chronic effects of a multistrain probiotic supplement on cognitive function and mood in healthy older adults: a randomized controlled trial. Am. J. Clin. Nutr. 121, 1268\u20131280 (2025).","journal-title":"Am. J. Clin. Nutr."},{"key":"1364_CR53","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/mds.22007","volume":"23","author":"J Pagonabarraga","year":"2008","unstructured":"Pagonabarraga, J. et al. Parkinson\u2019s Disease-Cognitive Rating Scale: a new cognitive scale specific for Parkinson\u2019s disease. Mov. Disord. 23, 998\u20131005 (2008).","journal-title":"Mov. Disord."},{"key":"1364_CR54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.parkreldis.2013.05.007","volume":"19","author":"J Kulisevsky","year":"2013","unstructured":"Kulisevsky, J. et al. Measuring functional impact of cognitive impairment: validation of the Parkinson\u2019s Disease Cognitive Functional Rating Scale. Parkinsonism Relat. Disord. 19, 812\u2013817 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1364_CR55","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1097\/MCG.0b013e318227414a","volume":"45","author":"ME Sanders","year":"2011","unstructured":"Sanders, M. E. Impact of probiotics on colonizing microbiota of the gut. J. Clin. Gastroenterol. 45, S115\u2013S119 (2011).","journal-title":"J. Clin. Gastroenterol."},{"key":"1364_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5056\/jnm22031","volume":"29","author":"A Tremblay","year":"2023","unstructured":"Tremblay, A. et al. Total transit time and probiotic persistence in healthy adults: a pilot study. J. Neurogastroenterol. Motil. 29, 218\u2013228 (2023).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"1364_CR57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.tim.2015.03.002","volume":"23","author":"M Derrien","year":"2015","unstructured":"Derrien, M. & van Hylckama Vlieg, J. E. T. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 23, 354\u2013366 (2015).","journal-title":"Trends Microbiol."},{"key":"1364_CR58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/gutjnl-2020-321747","volume":"70","author":"M Fassarella","year":"2021","unstructured":"Fassarella, M. et al. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health. Gut 70, 595\u2013605 (2021).","journal-title":"Gut"},{"key":"1364_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nlm.2017.05.015","volume":"144","author":"C O\u2019Hagan","year":"2017","unstructured":"O\u2019Hagan, C. et al. Long-term multi-species Lactobacillus and Bifidobacterium dietary supplement enhances memory and changes regional brain metabolites in middle-aged rats. Neurobiol. Learn. Mem. 144, 36\u201347 (2017).","journal-title":"Neurobiol. Learn. Mem."},{"key":"1364_CR60","doi-asserted-by":"publisher","first-page":"1900603","DOI":"10.1002\/mnfr.201900603","volume":"63","author":"Y Ni","year":"2019","unstructured":"Ni, Y. et al. Lactobacillus and Bifidobacterium improves physiological function and cognitive ability in aged mice by the regulation of gut microbiota. Mol. Nutr. Food Res. 63, 1900603 (2019).","journal-title":"Mol. Nutr. Food Res."},{"key":"1364_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12602-017-9322-6","volume":"10","author":"G La Fata","year":"2018","unstructured":"La Fata, G., Weber, P. & Mohajeri, M. H. Probiotics and the gut immune system: indirect regulation. Probiotics Antimicrob. Proteins 10, 11\u201321 (2018).","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"1364_CR62","first-page":"1739","volume":"05","author":"S van Hemert","year":"2014","unstructured":"van Hemert, S. & Ormel, G. Influence of the multispecies probiotic Ecologic\u00ae BARRIER on parameters of intestinal barrier function. Food Nutr. Sci. 05, 1739\u20131745 (2014).","journal-title":"Food Nutr. Sci."},{"key":"1364_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00524-6","volume":"10","author":"M Xiao","year":"2024","unstructured":"Xiao, M. et al. Cross-feeding of bifidobacteria promotes intestinal homeostasis: a lifelong perspective on the host health. NPJ Biofilms Microbiomes 10, 47 (2024).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"1364_CR64","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/mds.29959","volume":"39","author":"A Metcalfe-Roach","year":"2024","unstructured":"Metcalfe-Roach, A. et al. Metagenomic analysis reveals large-scale disruptions of the gut microbiome in Parkinson\u2019s disease. Mov. Disord. 39, 1740\u20131751 (2024).","journal-title":"Mov. Disord."},{"key":"1364_CR65","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/ajcn\/nqy041","volume":"107","author":"D So","year":"2018","unstructured":"So, D. et al. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am. J. Clin. Nutr. 107, 965\u2013983 (2018).","journal-title":"Am. J. Clin. Nutr."},{"key":"1364_CR66","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1007\/s00394-022-02802-5","volume":"61","author":"R Almutairi","year":"2022","unstructured":"Almutairi, R., Basson, A. R., Wearsh, P., Cominelli, F. & Rodriguez-Palacios, A. Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo-controlled clinical trials. Eur. J. Nutr. 61, 2853\u20132871 (2022).","journal-title":"Eur. J. Nutr."},{"key":"1364_CR67","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/apt.13788","volume":"44","author":"A Horvath","year":"2016","unstructured":"Horvath, A. et al. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment. Pharmacol. Ther. 44, 926\u2013935 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"1364_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81204-9","volume":"11","author":"PD Browne","year":"2021","unstructured":"Browne, P. D., Bolte, A. C., Besseling-van der Vaart, I., Claassen, E. & de Weerth, C. Probiotics as a treatment for prenatal maternal anxiety and depression: a double-blind randomized pilot trial. Sci. Rep. 11, 3051 (2021).","journal-title":"Sci. Rep."},{"key":"1364_CR69","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/mds.25919","volume":"29","author":"AFG Leentjens","year":"2014","unstructured":"Leentjens, A. F. G. et al. The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale. Mov. Disord. 29, 1035\u20131043 (2014).","journal-title":"Mov. Disord."},{"key":"1364_CR70","first-page":"100387","volume":"13","author":"JST Lam","year":"2025","unstructured":"Lam, J. S. T. et al. Validation of the English version of the Parkinson Anxiety Scale in two Canadian Parkinson\u2019s disease samples. Clin. Park. Relat. Disord. 13, 100387 (2025).","journal-title":"Clin. Park. Relat. Disord."},{"key":"1364_CR71","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.parkreldis.2015.07.018","volume":"21","author":"M Picillo","year":"2015","unstructured":"Picillo, M., Kou, N., Barone, P. & Fasano, A. Recruitment strategies and patient selection in clinical trials for Parkinson\u2019s disease: going viral and keeping science and ethics at the highest standards. Parkinsonism Relat. Disord. 21, 1041\u20131048 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1364_CR72","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s13311-020-00960-0","volume":"17","author":"PA Vaswani","year":"2020","unstructured":"Vaswani, P. A., Tropea, T. F. & Dahodwala, N. Overcoming barriers to Parkinson disease trial participation: increasing diversity and novel designs for recruitment and retention. Neurotherapeutics 17, 1724\u20131735 (2020).","journal-title":"Neurotherapeutics"},{"key":"1364_CR73","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/mds.25937","volume":"29","author":"NNNW Dissanayaka","year":"2014","unstructured":"Dissanayaka, N. N. N. W. et al. The clinical spectrum of anxiety in Parkinson\u2019s disease. Mov. Disord. 29, 967\u2013975 (2014).","journal-title":"Mov. Disord."},{"key":"1364_CR74","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/ene.13217","volume":"24","author":"K Zhu","year":"2017","unstructured":"Zhu, K., van Hilten, J. J. & Marinus, J. Onset and evolution of anxiety in Parkinson\u2019s disease. Eur. J. Neurol. 24, 404\u2013411 (2017).","journal-title":"Eur. J. Neurol."},{"key":"1364_CR75","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1017\/S1368980016001506","volume":"19","author":"I Csizmadi","year":"2016","unstructured":"Csizmadi, I. et al. Using national dietary intake data to evaluate and adapt the US Diet History Questionnaire: the stepwise tailoring of an FFQ for Canadian use. Public Health Nutr 19, 3247\u20133255 (2016).","journal-title":"Public Health Nutr"},{"key":"1364_CR76","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/jn\/136.6.1582","volume":"136","author":"C Weismayer","year":"2006","unstructured":"Weismayer, C., Anderson, J. G. & Wolk, A. Changes in the stability of dietary patterns in a study of middle-aged Swedish women. J. Nutr. 136, 1582\u20131587 (2006).","journal-title":"J. Nutr."},{"key":"1364_CR77","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1017\/S1368980014000111","volume":"17","author":"JM Harrington","year":"2014","unstructured":"Harrington, J. M., Dahly, D. L., Fitzgerald, A. P., Gilthorpe, M. S. & Perry, I. J. Capturing changes in dietary patterns among older adults: a latent class analysis of an ageing Irish cohort. Public Health Nutr. 17, 2674\u20132686 (2014).","journal-title":"Public Health Nutr."},{"key":"1364_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-019-0495-6","volume":"18","author":"MG Thorpe","year":"2019","unstructured":"Thorpe, M. G., Milte, C. M., Crawford, D. & McNaughton, S. A. Education and lifestyle predict change in dietary patterns and diet quality of adults 55 years and over. Nutr. J. 18, 67 (2019).","journal-title":"Nutr. J."},{"key":"1364_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1364_CR80","doi-asserted-by":"publisher","first-page":"3831972","DOI":"10.1155\/2017\/3831972","volume":"2017","author":"V Monda","year":"2017","unstructured":"Monda, V. et al. Exercise modifies the gut microbiota with positive health effects. Oxid. Med. Cell. Longev. 2017, 3831972 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1364_CR81","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/(SICI)1097-0258(19960715)15:13<1421::AID-SIM266>3.0.CO;2-H","volume":"15","author":"KE James","year":"1996","unstructured":"James, K. E., Bloch, D. A., Lee, K. K., Kraemer, H. C. & Fuller, R. K. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation\u2014a VA cooperative study. Stat. Med. 15, 1421\u20131434 (1996).","journal-title":"Stat. Med."},{"key":"1364_CR82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cct.2003.10.016","volume":"25","author":"H Bang","year":"2004","unstructured":"Bang, H., Ni, L. & Davis, C. E. Assessment of blinding in clinical trials. Control. Clin. Trials 25, 143\u2013156 (2004).","journal-title":"Control. Clin. Trials"},{"key":"1364_CR83","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbi.2017.04.017","volume":"65","author":"A Abildgaard","year":"2017","unstructured":"Abildgaard, A., Elfving, B., Hokland, M., Lund, S. & Wegener, G. Probiotic treatment protects against the pro-depressant-like effect of high-fat diet in Flinders Sensitive Line rats. Brain Behav. Immun. 65, 33\u201342 (2017).","journal-title":"Brain Behav. Immun."},{"key":"1364_CR84","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.psyneuen.2017.02.014","volume":"79","author":"A Abildgaard","year":"2017","unstructured":"Abildgaard, A., Elfving, B., Hokland, M., Wegener, G. & Lund, S. Probiotic treatment reduces depressive-like behaviour in rats independently of diet. Psychoneuroendocrinology 79, 40\u201348 (2017).","journal-title":"Psychoneuroendocrinology"},{"key":"1364_CR85","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea, M. S. et al. Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov. Disord. 35, 1208\u20131217 (2020).","journal-title":"Mov. Disord."},{"key":"1364_CR86","doi-asserted-by":"publisher","first-page":"1470149","DOI":"10.1155\/2017\/1470149","volume":"2017","author":"M Kov\u00e1cs","year":"2017","unstructured":"Kov\u00e1cs, M. et al. Prevalence of anxiety among Hungarian subjects with Parkinson\u2019s disease. Behav. Neurol. 2017, 1470149 (2017).","journal-title":"Behav. Neurol."},{"key":"1364_CR87","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.j. 17, 10\u201312 (2011).","journal-title":"EMBnet.j."},{"key":"1364_CR88","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1364_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0658-x","volume":"7","author":"EL Clarke","year":"2019","unstructured":"Clarke, E. L. et al. Sunbeam: an extensible pipeline for analyzing metagenomic sequencing experiments. Microbiome 7, 46 (2019).","journal-title":"Microbiome"},{"key":"1364_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).","journal-title":"Genome Biol."},{"key":"1364_CR91","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s44220-023-00148-3","volume":"1","author":"TFS Bastiaanssen","year":"2023","unstructured":"Bastiaanssen, T. F. S., Quinn, T. P. & Loughman, A. Bugs as features (part 1): concepts and foundations for the compositional data analysis of the microbiome\u2013gut\u2013brain axis. Nat. Ment. Health 1, 930\u2013938 (2023).","journal-title":"Nat. Ment. Health"},{"key":"1364_CR92","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/2041-210X.12613","volume":"7","author":"TC Hsieh","year":"2016","unstructured":"Hsieh, T. C., Ma, K. H. & Chao, A. iNEXT: an R package for rarefaction and extrapolation of species diversity (Hill numbers). Methods Ecol. Evol. 7, 1451\u20131456 (2016).","journal-title":"Methods Ecol. Evol."},{"key":"1364_CR93","doi-asserted-by":"publisher","first-page":"104248","DOI":"10.1016\/j.chemolab.2021.104248","volume":"210","author":"S Lubbe","year":"2021","unstructured":"Lubbe, S., Filzmoser, P. & Templ, M. Comparison of zero replacement strategies for compositional data with large numbers of zeros. Chemom. Intell. Lab. Syst. 210, 104248 (2021).","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"1364_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.105047","volume":"124","author":"TFS Bastiaanssen","year":"2021","unstructured":"Bastiaanssen, T. F. S. et al. Volatility as a concept to understand the impact of stress on the microbiome. Psychoneuroendocrinology 124, 105047 (2021).","journal-title":"Psychoneuroendocrinology"},{"key":"1364_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-017-0442-1","volume":"17","author":"JC Jakobsen","year":"2017","unstructured":"Jakobsen, J. C., Gluud, C., Wetterslev, J. & Winkel, P. When and how should multiple imputation be used for handling missing data in randomised clinical trials\u2014a practical guide with flowcharts. BMC Med. Res. Methodol. 17, 162 (2017).","journal-title":"BMC Med. Res. Methodol."},{"key":"1364_CR96","doi-asserted-by":"crossref","unstructured":"van Buuren, S. & Groothuis-Oudshoorn, K. mice: Multivariate imputation by chained equations in R. J. Stat. Softw. 45, 1\u201367 (2011).","DOI":"10.18637\/jss.v045.i03"},{"key":"1364_CR97","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01364-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:02:12Z","timestamp":1780729332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01364-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01364-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}